Naomi Watts – the star of the fashion campaign dedicated to the fight against ovarian cancer, created by designers Camilla and Marc Freeman

British actress Naomi Watts, known from films such as King Kong, Insurgent, The Ring or Blonde, together with Dree Hemingway, Georgia Fowler and Willa Devereux are icons of an important campaign with a deep sentimental value for fans Australian designers Camilla Freeman-Topper and Marc Freeman, who are behind the label Camilla and Marc. The brand’s campaign is dedicated to the fight against ovarian cancer and the work the brothers are doing through their campaign, Ovaries. Talk about them.

“My brother Marc and I lost our mother to ovarian cancer when we were only 11 and 13 respectively. That was 30 years ago now, and since then the statistics for this disease have changed very little. There was no testing then and there is no testing now and that is simply due to lack of funding and a systemic bias in the health care system against women“creative director Freeman-Topper said in an interview. The brothers have raised $1.7 million for ovarian cancer research over the past four years, with 100% of the money going directly to the cause.

Freeman and Freeman-Topper hope that their efforts to raise awareness through their capsule collections and special ambassadors will help their early research enter clinical trials by 2026. The brothers worked with Dr. Kristina Warton, lead researcher at the University of New South Wales Gynecological Cancer Research Group.

“Our goal is to make this test successful with a simple blood draw and PCR reaction, without the need for special imaging equipment or invasive medical procedures.“, said the doctor.

“This is an issue at the heart of any community. It is our responsibility to use appropriate methods to make changes for the community and for future generations. [Naomi] she is also a strong advocate for women, the work she is doing to raise awareness and defuse conversations about women’s health is inspiring and something that fits perfectly with our campaign.Freeman-Topper added.

Ovarian cancer patients have an average five-year survival rate of 49%, compared to 92% for breast cancer, 84% for uterine cancer and 74% for breast cancer. But when ovarian cancer is identified at stage one, patients’ chances of survival increase to more than 90 percent. This is why the development of an early detection test is so importantcelebrates Dr Kristina Warton, Principal Scientist at the Gynecological Cancer Research Group – UNSW.

“Early detection testing aims to improve outcomes and save lives for people with ovarian cancer worldwide“, she explains.”Early diagnosis, before the tumor has spread, is the most accessible and equitable route to healthcare for people at risk of ovarian cancer and can have a life-changing impact on those diagnosed with it. the disease.”